Insulet Corp. ( PODD) - Key Metrics
PODD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $11.57 | $1.37 | $1.28 | $0.86 |
| 2026Q1 | $10.88 | $1.30 | $1.63 | $1.23 |
| 2025Q4 | $11.14 | $1.44 | $2.61 | $0.69 |
| 2025Q3 | $10 | $1.24 | $1.78 | $1.48 |
| 2025Q2 | $9.23 | $0.32 | $2.79 | $2.46 |
PODD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 27.78 |
| 2026Q1 | 0% | 40.35 |
| 2025Q4 | 0% | 49.01 |
| 2025Q3 | 0% | 62.24 |
| 2025Q2 | 0% | 245.45 |
PODD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.56% | 0% |
| 2026Q1 | 0.59% | 0% |
| 2025Q4 | 0.24% | 0% |
| 2025Q3 | 0.48% | 0% |
| 2025Q2 | 0.78% | 0% |
PODD
Price: $134.24
52 week price:
Earnings Per Share: 5.33 USD
P/E Ratio: 27.15
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 334800
Ebitda: 6.4 millionMarket Capitalization: 9.1 billion